299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02782312 (ClinicalTrials.gov)	June 2011	17/5/2016	Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis	Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis With Airway Limitation: a Prospective Study	Bronchiectasis	Drug: ICS+LABA;Other: routine therapy	Shanghai Pulmonary Hospital, Shanghai, China	NULL	Completed	18 Years	N/A	Both	120	Phase 4	China
2	NCT00005110 (ClinicalTrials.gov)	April 2000	13/4/2000	A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis		Cystic Fibrosis	Drug: Salmeterol;Drug: Albuterol	National Center for Research Resources (NCRR)	NULL	Suspended	5 Years	45 Years	Both		N/A	United States